InvestorsHub Logo
Followers 1
Posts 269
Boards Moderated 0
Alias Born 05/08/2017

Re: Grip it and Sip It post# 53375

Tuesday, 01/21/2020 3:08:16 PM

Tuesday, January 21, 2020 3:08:16 PM

Post# of 232425


For a civilized debate smile

The science is overwhelming

I wholeheartedly agree with you

BLA is on us. Financing is on us. Missed timelines is on us!



BLA: We where ready many months ago. FDA required 700 mg data from MONO, yes MONO, Forgive me from saying: victims of our own success. We did not have the stability data as it was assumed that 525mg was going to be THE dosage.

Financing: Yup, on us. Who else ???

Missed timelines: Not completely on us, FDA delayed us greatly requiring the 700mg MONO data and afterwards on telling us what is really what they wanted as far as dosage. Not our fault at all.

all he’s really gotten done was a deal with a third-rate company.



Unfair. He has advanced possible 20 Cancer indications plus 10 possible immunology plus HIV, both combo and Mono. The price sits at $1 dollar, like it or not we are a $470M MC company.

He stated in December that it would DEFINITELY be by end of December or first week of January.

He didn't. He said that if the FDA decided on the dosage we would probably have them ready by then.

Also, I believe it was mentioned a potential $40-50M non-dilutive financing possibly. When is Nader going to learn to keep his mouth shut until the ink is dry!



Yes he has, yes it will come. I hope he keeps communicating with us often. Even before the ink is dry. I like it. I have shares in other companies and, believe me, I would love to have the openness from their CEOs that NP brings. It allows me to make more educated decisions.


competitors will be nipping at our heels


It will always happen, however Leronlimab is a very difficult antibody to compete against. Science continues and Cancer patients will be happy to hear that. For us. investors, the opportunity is there if we can discover emerging technologies before every man and his dog know about them.








Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News